Sava Infond D.O.O. Eli Lilly & CO Transaction History
Sava Infond D.O.O.
- $640 Billion
- Q2 2025
A detailed history of Sava Infond D.O.O. transactions in Eli Lilly & CO stock. As of the latest transaction made, Sava Infond D.O.O. holds 9,560 shares of LLY stock, worth $8.57 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
9,560
Previous 9,650
0.93%
Holding current value
$8.57 Million
Previous $7.97 Billion
6.5%
% of portfolio
1.16%
Previous 1.52%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
4,471Shares Held
779MCall Options Held
16.9MPut Options Held
12.6M-
Lilly Endowment Inc Indianapolis, IN95.5MShares$85.6 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$72.1 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$59 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$46 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$30.9 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $852B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...